Skip to main content Accessibility help
×
Home

Dimensional thinking in psychiatry in the era of the Research Domain Criteria (RDoC)

  • J. R. Kelly (a1) (a2), G. Clarke (a1) (a2), J. F. Cryan (a2) (a3) and T. G. Dinan (a1) (a2)

Abstract

The biological mechanisms underlying psychiatric diagnoses are not well defined. Clinical diagnosis based on categorical systems exhibit high levels of heterogeneity and co-morbidity. The Research Domain Criteria (RDoC) attempts to reconceptualize psychiatric disorders into transdiagnostic functional dimensional constructs based on neurobiological measures and observable behaviour. By understanding the underlying neurobiology and pathophysiology of the relevant processes, the RDoC aims to advance biomarker development for disease prediction and treatment response. This important evolving dimensional framework must also consider environmental factors. Emerging evidence suggests that gut microbes (microbiome) play a physiological role in brain diseases by modulating neuroimmune, neuroendocrine and neural signalling pathways between the gut and the brain. The integration of the gut microbiome signature as an additional dimensional component of the RDoC may enhance precision psychiatry.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Dimensional thinking in psychiatry in the era of the Research Domain Criteria (RDoC)
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Dimensional thinking in psychiatry in the era of the Research Domain Criteria (RDoC)
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Dimensional thinking in psychiatry in the era of the Research Domain Criteria (RDoC)
      Available formats
      ×

Copyright

Corresponding author

*Address for correspondence: Dr J. R. Kelly, Lecturer in Clinical Psychiatry, Department of Psychiatry and Neurobehavioural Science, Biosciences Institute, University College Cork, Cork, Ireland. (Email: johnkelly@ucc.ie)

References

Hide All
Adam, D (2013). Mental health: on the spectrum. Nature 496, 416418.
Alexopoulos, GS, Arean, P (2014). A model for streamlining psychotherapy in the RDoC era: the example of ‘engage’. Molecular Psychiatry 19, 1419.
Baca-Garcia, E, Perez-Rodriguez, MM, Basurte-Villamor, I, Del Moral, ALF, Jimenez-Arriero, MA, De Rivera, JLG, Saiz-Ruiz, J, Oquendo, MA (2007). Diagnostic stability of psychiatric disorders in clinical practice. The British Journal of Psychiatry 190, 210216.
Bebbington, PE, Mcbride, O, Steel, C, Kuipers, E, Radovanovič, M, Brugha, T, Jenkins, R, Meltzer, HI, Freeman, D (2013). The structure of paranoia in the general population. The British Journal of Psychiatry 202, 419427.
Carpenter, WT (2013). RDoC and DSM-5: what’s the fuss? Schizophrenia Bulletin 39, 945946.
Catalan, A, Gonzalez, DE, Artaza, M, Bustamante, S, Orgaz, P, Osa, L, Angosto, V, Valverde, C, Bilbao, A, Madrazo, A, Van OS, J, Gonzalez-Torres, MA (2016). Differences in facial emotion recognition between first episode psychosis, borderline personality disorder and healthy controls. PLoS One 11, e0160056.
Chekroud, AM, Zotti, RJ, Shehzad, Z, Gueorguieva, R, Johnson, MK, Trivedi, MH, Cannon, TD, Krystal, JH, Corlett, PR (2016). Cross-trial prediction of treatment outcome in depression: a machine learning approach. Lancet Psychiatry 3, 243250.
Chekroud, AM, Gueorguieva, R, Krumholz, HM, Trivedi, MH, Krystal, JH, McCarthy, G (2017). Reevaluating the efficacy and predictability of antidepressant treatments: a symptom clustering approach. JAMA Psychiatry.
Craddock, N, Owen, MJ (2010). The Kraepelinian dichotomy – going, going … but still not gone. The British Journal of Psychiatry 196, 9295.
Cryan, JF, Dinan, TG (2012). Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience 13, 701712.
Dimasi, JA, Hansen, RW, Grabowski, HG (2003). The price of innovation: new estimates of drug development costs. Journal of Health Economics 22, 151185.
Drysdale, AT, Grosenick, L, Downar, J, Dunlop, K, Mansouri, F, Meng, Y, Fetcho, RN, Zebley, B, Oathes, DJ, Etkin, A, Schatzberg, AF, Sudheimer, K, Keller, J, Mayberg, HS, Gunning, FM, Alexopoulos, GS, Fox, MD, Pascual-Leone, A, Voss, HU, Casey, BJ, Dubin, MJ, Liston, C (2017). Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 23, 2838.
Garn, H, Bahn, S, Baune, BT, Binder, EB, Bisgaard, H, Chatila, TA, Chavakis, T, Culmsee, C, Dannlowski, U, Gay, S, Gern, J, Haahtela, T, Kircher, T, Muller-Ladner, U, Neurath, MF, Preissner, KT, Reinhardt, C, Rook, G, Russell, S, Schmeck, B, Stappenbeck, T, Steinhoff, U, Van OS, J, Weiss, S, Zemlin, M, Renz, H (2016). Current concepts in chronic inflammatory diseases: interactions between microbes, cellular metabolism, and inflammation. Journal of Allergy and Clinical Immunology 138, 4756.
Goldberg, D (2011). The heterogeneity of ‘major depression’. World Psychiatry 10, 226228.
Gururajan, A, Clarke, G, Dinan, TG, Cryan, JF (2016). Molecular biomarkers of depression. Neuroscience & Biobehavioral Reviews 64, 101133.
Henje Blom, E, Duncan, LG, Ho, TC, Connolly, CG, Lewinn, KZ, Chesney, M, Hecht, FM, Yang, TT (2014). The development of an RDoC-based treatment program for adolescent depression: ‘Training for Awareness, Resilience, and Action’ (TARA). Frontiers in Human Neuroscience 8, 630.
Hulshoff Pol, HE, Van Baal, GC, Schnack, HG, Brans, RG, Van Der Schot, AC, Brouwer, RM, Van Haren, NE, Lepage, C, Collins, DL, Evans, AC, Boomsma, DI, Nolen, W, Kahn, RS (2012). Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder. Archives of General Psychiatry 69, 349359.
Insel, T, Cuthbert, B, Garvey, M, Heinssen, R, Pine, DS, Quinn, K, Sanislow, C, Wang, P (2010). Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. The American Journal of Psychiatry 167, 748751.
Insel, TR (2012). Next-generation treatments for mental disorders. Science Translational Medicine 4, 155.
Insel, TR, Cuthbert, BN (2015). Medicine. Brain disorders? Precisely. Science 348, 499500.
Insel, TR, Voon, V, Nye, JS, Brown, VJ, Altevogt, BM, Bullmore, ET, Goodwin, GM, Howard, RJ, Kupfer, DJ, Malloch, G, Marston, HM, Nutt, DJ, Robbins, TW, Stahl, SM, Tricklebank, MD, Williams, JH, Sahakian, BJ (2013). Innovative solutions to novel drug development in mental health. Neuroscience and Biobehavioral Reviews 37, 24382444.
Joyce, DW, Kehagia, AA., Tracy, DK, Proctor, J, Shergill, SS (2017). Realising stratified psychiatry using multidimensional signatures and trajectories. Journal of Translational Medicine 15, 15.
Kapur, S, Phillips, AG, Insel, TR (2012). Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Molecular Psychiatry 17, 11741179.
Kelly, JR, Borre, Y, O’Brien, C, Patterson, EEL, Aidy, S, Deane, J, Kennedy, PJ, Beers, S, Scott, K, Moloney, G, Hoban, AE, Scott, L, Fitzgerald, P, Ross, P, Stanton, C, Clarke, G, Cryan, JF, Dinan, TG (2016a). Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. Journal of Psychiatric Research 82, 109118.
Kelly, JR, Clarke, G, Cryan, JF, Dinan, TG (2016b). Brain-gut-microbiota axis: challenges for translation in psychiatry. Annals of Epidemiology 26, 366372.
Kraemer, HC (2015). Research Domain Criteria (RDoC) and the DSM-two methodological approaches to mental health diagnosis. JAMA Psychiatry 72, 11631164.
Krishnan, V, Nestler, EJ (2010). Linking molecules to mood: new insight into the biology of depression. The American Journal of Psychiatry 167, 13051320.
Lehner, T, Insel, T (2010). Psychiatric education in the genomic era. Academic Psychiatry 34, 8789.
Mayer, EA, Knight, R, Mazmanian, SK, Cryan, JF (2014). Gut microbes and the brain: paradigm shift in neuroscience. Journal of Neuroscience 34, 1549015496.
Miller, G (2010). Is pharma running out of brainy ideas? Science 329, 502504.
Miller, GA, Rockstroh, B (2013). Endophenotypes in psychopathology research: where do we stand? Annual Review of Clinical Psychology 9, 177213.
Mukherjee, K, Maier, M, Wessely, S (2013). UK crisis in recruitment into psychiatric training. The Psychiatrist 37, 210214.
Murphy, R, Hallahan, B (2016). Differences between DSM-IV and DSM-5 as applied to general adult psychiatry. Irish Journal of Psychological Medicine 33, 135141.
Naughton, M, Clarke, G, O’leary, OF, Cryan, JF, Dinan, TG (2014). A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. Journal of Affective Disorders 156, 2435.
Roffman, JL, Simon, AB, Prasad, KM, Truman, CJ, Morrison, J, Ernst, CL (2006). Neuroscience in psychiatry training: how much do residents need to know? The American Journal of Psychiatry 163, 919926.
Ross, DA, Arbuckle, MR, Travis, MJ (2015a). ‘The time is now’: integrating neuroscience into psychiatry training. Asian Journal of Psychiatry 17, 126127.
Ross, DA, Travis, MJ, Arbuckle, MR (2015b). The future of psychiatry as clinical neuroscience: why not now? JAMA Psychiatry 72, 413414.
Schumann, G, Binder, EB, Holte, A, De Kloet, ER, Oedegaard, KJ, Robbins, TW, Walker-Tilley, TR, Bitter, I, Brown, VJ, Buitelaar, J, Ciccocioppo, R, Cools, R, Escera, C, Fleischhacker, W, Flor, H, Frith, CD, Heinz, A, Johnsen, E, Kirschbaum, C, Klingberg, T, Lesch, KP, Lewis, S, Maier, W, Mann, K, Martinot, JL, Meyer-Lindenberg, A, Muller, CP, Muller, WE, Nutt, DJ, Persico, A, Perugi, G, Pessiglione, M, Preuss, UW, Roiser, JP, Rossini, PM, Rybakowski, JK, Sandi, C, Stephan, KE, Undurraga, J, Vieta, E, Van Der Wee, N, Wykes, T, Haro, JM, Wittchen, HU (2014). Stratified medicine for mental disorders. European Neuropsychopharmacology 24, 550.
Smoller, JW, Ripke, S, Lee, PH, Neale, B, Nurnberger, JI, Santangelo, S, Sullivan, PF, Perlis, RH, Purcell, SM, Fanous, A, Neale, MC, Rietschel, M, Schulze, TG, Thapar, A, Anney, R, Buitelaar, JK, Farone, SV, Hoogendijk, WJ, Levinson, DF, Lesch, KP, Riley, B, Schachar, R, Sonuga-Barke, E, Absher, D, Agartz, I, Akil, H, Amin, F, Andreassen, OA, Anjorin, A, Arking, D, Asherson, P, Azevedo, MH, Backlund, L, Badner, JA, Banaschewski, T, Barchas, JD, Barnes, MR, Bass, N, Bauer, M, Bellivier, F, Bergen, SE, Berrettini, W, Bettecken, T, Biederman, J, Binder, EB, Black, DW, Blackwood, DH, Bloss, CS, Boehnke, M, Boomsma, DI, Breen, G, Breuer, R, Buccola, NG, Bunner, WE, Burmeister, M, Buxbaum, JD, Byerley, WF, Sian, C, Cantor, RM, Chakravarti, A, Chambert, K, Chicon, S, Cloniger, CR, Collier, DA, Cook, E, Coon, H, Corvin, A, Coryell, WH, Craig, DW, Craig, IW, Curtis, D, Czamara, D, Daly, M, Datta, S, Day, R, De Geus, EJ, Degenhardt, F, Devlin, B, Srdjan, D, Doyle, AE, Duan, J, Dudbridge, F, Edenberg, HJ, Elkin, A, Etain, B, Farmer, AE, Ferreira, MA, Ferrier, IN, Flickinger, M, Foroud, T, Frank, J, Franke, B, Fraser, C, Freedman, R, Freimer, NB, Friedl, M, Frisén, L, Gejman, PV, Georgieva, L, Gershon, ES, Giegling, I, Gill, M, Gordon, SD, Gordon-Smith, K, Green, EK, Greenwood, TA, Gross, M, , G. D., Guan, , W, Gurling, , H, Gustafsson, , Ó, Hakonarson, , H, Hamilton, , SP, Hamshere, , ML, Hansen, , TF, Hartmann, , AM, Hautzinger, , M, Heath, , AC, Henders, , AK, Herms, , S, Hickie, , IB, Hipolito, , M, Hoefels, , S, Holmans, , PA, Holsboer, , F, Hottenga, , JJ, Hultman, , CM, IngasonA, I. M. A, I. M., Jamain, S, Jones, EG, Jones, L, Jones, I, Jung-Ying, T, Kahler, A, Kandaswamy, R, Keller, MC, Kelsoe, JR, Kennedy, JL, Kenny, E, Kim, Y, Kirov, GK, Knowles, JA, Kohli, MA, Koller, DL, Konte, B, Korszun, A, Krasucki, R, Kuntsi, J, Phoenix, K, Landén, M, Langstrom, N, Lathrop, M, Lawrence, J, Lawson, WB, Leboyer, M, Lencz, T L. K., Lewis, CM, Li, J, Lichtenstein, P, Lieberman, JA, Lin, D, Liu, C, Lohoff, FW, Loo, SK, Lucae, S, MacIntyre, D, Madden, PA, Magnusson, P, Mahon, PB, Maier, W, Malhotra, AK, Mattheisen, M, Matthews, K, Mattingsdal, M, McCarroll, S, McGhee, KA, McGough, JJ, McGrath, PJ, McGuffin, P, McInnis, MG, McIntosh, A, McKinney, R, McClean, AW, McMahon, FJ, McQuillin, A, Medeiros, H, Medland, SE, Meier, S, Melle, I, Meng, F, Middeldorp, CM, Middleton, L, Vihra, M, Mitchell, PB, Montgomery, GW, Moran, J, Morken, G, Morris, DW, Moskvina, V, Mowry, BJ, Muglia, P, Mühleisen, TW, Muir, WJ, Müller-Myhsok, B, Myers, RM, Nelson, SF, Nievergelt, CM, Nikolovq, I, Nimgaonkar, V, Nolen, WA, Nöthen, MM, Nwulia, EA, Nyholt, DR, O’Donovan, MC, O’Dushlaine, C, Oades, RD, Olincy, A, Olsen, L, Ophoff, RA, Osby, U, Óskarsson, H, Owen, MJ, Palotie, A, Pato, MT, Pato, CN, Penninx, BP, Pergadia, ML, Petursson, H, Pickard, BS, Pimm, J, Piven, J, Porgeirsson, P, Posthuma, D, Potash, JB, Propping, J, Puri, V, Quested, D, Quinn, EM, Rasmussen, HB, Raychaudhuri, S, Rehnström, K, Reif, A, Rice, J, Rossin, L, Rothenberger, A, Rouleau, G, Ruderfer, D, Rujescu, D, Sanders, AR, Schalling, M, Schatzberg, AF, Schftner, WA, Schellenberg, G, Schofield, PR, Schork, NJ, Schumacher, J, Schwarz, MM, Scolnick, E, Scott, LJ, Shi, J, Shillling, PD, Shyn, SI, Sigurdsson, E, Silverman, JM, SklarP, S. S. P, S. S., Smalley, SL, Smit, JH, Smith, EN, Sonuga-Barke, E, St Clair, , D, State, M, Stefansson, , K, Stefansson, H, Steffans, , M, Steinberg, , S, Steinhausen, HC, Strauss, J, Strohmaier, J, Stroup, TS, Sutcliffe, J, Szatmari, P, Szelinger, S, Thirumalai, S, Thompson, RC, Tozzi, F, Treutlein, J, Uhr, M, van den Oord, EJ, Van Grootheest, G, Vieland, V, Vincent, JB, Visscher, PM, Watson, SJ, Weissman, MM, Werge, T, Wienker, TF, Willemsen, G, Williamson, R, Witt, SH, Wray, NR, WrightA, X. W. A, X. W., Young, AH, Zammit, S, Zandi, PP, Zhang, P, Zitman, FG, Zöllner, S, Craddock, N, K., K. (2013). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 13711379.
Swardfager, W, Rosenblat, JD, Benlamri, M, Mcintyre, RS (2016). Mapping inflammation onto mood: inflammatory mediators of anhedonia. Neuroscience & Biobehavioral Reviews 64, 148166.
Trivedi, MH, Rush, AJ, Wisniewski, SR, Nierenberg, AA, Warden, D, Ritz, L, Norquist, G, Howland, RH, Lebowitz, B, Mcgrath, PJ, Shores-Wilson, K, Biggs, MM, Balasubramani, GK, Fava, M (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. The American Journal of Psychiatry 163, 2840.
Umbricht, D, Alberati, D, Martin-Facklam, M, Borroni, E, Youssef, EA, Ostland, M, Wallace, TL, Knoflach, F, Dorflinger, E, Wettstein, JG, Bausch, A, Garibaldi, G, Santarelli, L (2014). Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study. JAMA Psychiatry 71, 637646.
Yee, CM, Javitt, DC, Miller, GA (2015). Replacing DSM categorical analyses with dimensional analyses in psychiatry research: the Research Domain Criteria initiative. JAMA Psychiatry 72, 11591160.

Keywords

Dimensional thinking in psychiatry in the era of the Research Domain Criteria (RDoC)

  • J. R. Kelly (a1) (a2), G. Clarke (a1) (a2), J. F. Cryan (a2) (a3) and T. G. Dinan (a1) (a2)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed